WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'4601 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 4'6691 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 3'461  3'487  3'514  3'543  3'573  4'107  4'364  4'010 
Births 42  42  43  44  44  48  81  85 
Surviving infants 41  42  42  43  44  47  78  81 
Pop. less than 5 years 207  215  222  223  215  255  427  378 
Pop. less than 15 years 576  577  583  589  596  974  1'218  1'072 
Female 15-49 years 895  911  928  945  962  1'096  1'101  1'074 

Number of reported case

(Click for retrospective incidence data for Republic of Moldova (the))
Diphtheria 10 
Japanese encephalitis
Measles 27  11  687  3'242 
Mumps 51  60  131  143  144  1'942 
Pertussis 188  115  92  102  31  169  266 
Polio*
Rubella 2'803 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Republic of Moldova (the))
Vaccine year result method % card seen                                                
BCG 2011  98  MICS   95  97  96  99  98  98  99 
DTP1 2011  96  MICS   95  94  86  91  96  93  94 
DTP3 2011  93  MICS   95  90  90  92  93  90  95 
HepB_BD          96  95  99  99  99  93 
HepB3 2011  94  MICS   95  92  91  94  96  98  92 
Hib3          89  89  90  78  63 
JapEnc         
MCV          90  91  91  91  97  89 
MCV2          93  94  95  97  98 
PCV1          83  17 
PCV3          72 
Pol3 2011  94  MICS   95  92  92  92  96  97  97 
Rota1          75  72  94 
Rota_last          69  65  93 
Rubella1          90  91  91  91  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Republic of Moldova (the))
BCG 96  99  98  98  99 
DTP1 96  97  96  93  98 
DTP3 90  92  93  90  95 
HepB3 91  94  96  98  92 
HepB_BD 95  99  99  98  93 
Hib3 89  90  78  63 
MCV 91  91  91  97  89 
MCV2 94  95  96  98 
PCV3
Pol3 92  92  96  97  97 
Rota_last 65  21 

Number of districts in the country 44  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 73
From 80 to 89% 23
From 50 to 79% 5
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 days; Yes
DT 7 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepA No contact in the centers, children residential care
HepB_Adult Yes risk groups
HepB_Pediatric 1 day; Yes
IPV 6 months; Yes from October 2015
Influenza_Adult Yes Pregnant women, health care workers, adults with chronic diseases and other risk groups
Influenza_Pediatric Yes children at risk and with chronic diseases
MMR 12 months; 7, 15 years; Yes
OPV 2, 4, 6 months; 2, 7, 15 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 15, 20, 25, 30, 35, 40, 50, 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 44  44  44  44  44  44  44 

System performance

Total Nº districts in country number 44  44  44  44  44  44  43 
Nº districts with DTP3 coverage >=80% number 42  41  42  42  40  38  41 
% of districts with DTP3 coverage >=80% From 0 to 100% 95  93  95  95  91  86  95 
Nº districts with measles (MCV1) coverage >=95% number 17  18  22  30  37  25  32 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  41  50  68  84  57  74 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 67  24      58     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.